Actualités

The market applauded Rocket Lab's potential expansion into the satellite business, reinforcing the company's ambitions for growth in space applications.

The Omaha-based conglomerate now has sizable exposure to artificial intelligence.

Most investors are unaware of this stock, which is up 30% year to date.

Micron stock has more than tripled so far in 2026, and recently became a member of the trillion-dollar club.

SpaceX has been a rocket, but rockets can explode.

The life insurance business model will be a big winner if rates stay high or rise even further.

The REX FANG & Innovation Equity Premium Income ETF (NASDAQ:FEPI) is one of the most aggressive volatility-income products on the market, selling calls against a concentrated basket of AI and mega-cap tech names to fund weekly cash distributions. Recent payouts have run roughly $0.21 per week against a share price of about $42, which annualizes ... FEPI’s 25% Yield Masks a Painful Truth About Call-Writing Income

The maker of small modular reactors deserves some more attention.

Despite a fantastic 711% trailing-10-year return, Netflix shares are currently 45% off their peak.

The upside and risks associated with ASML are more important to long-term shareholders than a stock split.

Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two different playbooks for winning in healthcare. Lilly is riding a GLP-1 wave. JNJ is proving that a wide, refreshed portfolio can still compound. Both raised guidance and both are worth putting side by side right now. GLP-1 Fireworks ... Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

This under-the-radar company doesn't get the recognition that semiconductor specialists receive -- but it certainly should.

Rocket Lab's bold takeover of Iridium could help it keep up with SpaceX.

The slump in oil prices has made this oil stock a no-brainer buy right now.

Procter & Gamble (NYSE:PG) and Colgate-Palmolive (NYSE:CL) both posted top and bottom line beats in their most recent quarters. PG’s fiscal Q3 2026 leaned on Beauty and broad regional strength. Colgate’s Q1 2026 leaned on Latin America and Hill’s Pet. Same shelf, very different engines. Beauty Powers P&G. Latin America Powers Colgate. P&G’s headline was ... Procter & Gamble vs Colgate-Palmolive: Two Consumer Giants, Two Strategies, One Invests, Other Optimizes

I want to AI-proof my finances.

Should investors fear the gold stock's recent decline or buy the dip?

The AI infrastructure company still has a bright future.

SpaceX stock is 19% off its peak.

The massive spending by hyperscalers is creating massive demand for reliable energy solutions.

Arm Holdings (NASDAQ:ARM) has been one of 2026’s most dramatic stories, ripping from a January low near $105 to a record $452.70 in June before giving back gains. With shares now near $315, the question is whether the AI CPU thesis still has room to run or if the easy money has already been made. ... Why Arm Is a Strong Buy Despite the 35% Pullback From Peak Levels

These companies each get a lot of attention, but for completely different reasons.

Artificial intelligence is reshaping entire industries, but many of the biggest winners may not be the companies investors expect.

The next month or so could be great for XRP, but the good times might not last.

TSMC builds key components of the AI revolution, and that unique position could make it the next company to join the exclusive $3 trillion market-cap club.

The stock is now the seventh-most valuable company in the world by market cap.

History suggests that Wall Street's storybook rally under President Donald Trump is about to come to an abrupt end.

The two stocks cater to different types of investors, but there's a clear winner for people who want the potential for higher returns.

Here's what investors need to know about why Nebius shares soared in June, but did an about-face in July.

Our Coinbase (NASDAQ:COIN) call is unabashedly constructive. Shares have been battered in 2026, but the setup into the back half of the year looks compelling if crypto volumes normalize and the cost-out plan sticks. The 24/7 Wall St. price target for Coinbase is $360.19 over the next 12 months, implying 117.66% upside from $165.48. Our ... Prediction: Coinbase Has Over 100% Upside as Cost Cuts and Volume Recovery Drive The Stock Higher